Document is current
Any future updates will be listed below
-
Authors
Rozevska, Marija
Kanepa, Adine
Purina, Signe
Gailite, Linda
Nartisa, Inga
Farkas, Henriette
Rots, Dmitrijs
Kurjane, Natalja https://orcid.org/0000-0002-8040-2127
-
Funding
Funding for this research was provided by:
Latvijas Zinātnes Padome (lzp-2020/1-0269)
- License Information
-
More Information
Article History
Received: 26 January 2024
Accepted: 14 March 2024
First Online: 30 March 2024
Declarations
:
: All individuals consented for the participation in the study. This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Central Board of the Ethical Committee of the Health Ministry of the Republic of Latvia (No. 01-29.1/2878).
: All authors, with the exception of H.F., declare no conflicts of interest. H.F. received research grants from CSL Behring, Takeda and Pharming and served as an advisor for these companies and Kalvista, ONO Pharmaceutical, Pharvaris, ASTRIA, Intellia and Biocryst, and has participated in clinical trials/registries for BioCryst, CSL Behring, Pharming, Kalvista, Pharvaris, Takeda.
